Comparison of 12 Molecular Detection Assays for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Molecular testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the mainstay for accurate diagnosis of the infection, but the diagnostic performances of available assays have not been defined. We compared 12 molecular diagnostic assays, including 8 commercial kits using 155 respiratory samples (65 nasopharyngeal swabs, 45 oropharyngeal swabs, and 45 sputum) collected at 2 Japanese hospitals. Sixty-eight samples were positive for more than one assay and one genetic locus and were defined as true positive samples.
Source: Journal of Molecular Diagnostics - Category: Pathology Authors: Yasufumi Matsumura, Tsunehiro Shimizu, Taro Noguchi, Satoshi Nakano, Masaki Yamamoto, Miki Nagao Tags: Regular Article Source Type: research
More News: Coronavirus | COVID-19 | Genetics | Hospitals | Japan Health | Pathology | Respiratory Medicine | SARS